-
Jafron Biomedical Annual Report 2021: Strong Devel...2023-01-17 -
One to One Program – Living Well with Dialysis2023-01-17 -
Jafron Presents at the 59th ERA Congress2023-01-17 -
HA230 Applied in a Patient Suffering from Severe D...2023-01-17 -
Jafron Biomedical at the 40th Vicenza Course on AK...2023-01-17 -
A Clinical Case about Septic Shock from Vietnam2023-01-17 -
The way forward of Jafron in Europe2023-01-17 -
Jaforn in Jordan: Facilitator of the Local Healthc...2023-01-17 -
Jafron HA130 in Medical Research: Another Breakthr...2023-01-17
-
Jafron Biomedical Annual Report 2021: Strong Development2023-01-17
-
One to One Program – Living Well with Dialysis2023-01-17
-
Jafron Presents at the 59th ERA Congress2023-01-17
-
HA230 Applied in a Patient Suffering from Severe Deltamethrin Poisoning2023-01-17
-
Jafron Biomedical at the 40th Vicenza Course on AKI&CRRT2023-01-17
-
A Clinical Case about Septic Shock from Vietnam2023-01-17
-
The way forward of Jafron in Europe2023-01-17
-
Jaforn in Jordan: Facilitator of the Local Healthcare Industry2023-01-17
-
Jafron HA130 in Medical Research: Another Breakthrough2023-01-17
Jafron Biomedical Co., Ltd.
Dirección: No. 98 Technology Six Road, High-tech Zone, Zhuhai City, China
Correo electrónico: customerservice@jafron.com
Sitio web: https://es.jafroninternational.com
Términos de uso｜Mapa del sitio｜ Aviso de cookies｜ Aviso de privacidad
Aviso de privacidad de la contratación
Línea directa disponible 24 horas al día, 7 días a la semana
© 2016 Jafron Biomedical Co., Ltd. Todos los derechos reservados.
